Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)
CVS Health Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) increased by 0.5% to $2.15B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.9%, from $2.41B to $2.15B. Over 5 years (FY 2020 to FY 2025), Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) shows a downward trend with a -6.5% CAGR.
Analysis
How to read this metric
An increase may indicate excess cash deployment or restricted capital, while a decrease suggests liquidation for operational needs or capital projects.
Detailed definition
This represents financial instruments or securities held by the company that are intended to be held for longer than one...
Peer comparison
Common in capital-intensive industries; peers often hold similar balances to meet regulatory requirements or long-term funding obligations.
non_current_assets_short_term_investmentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.01B | $3.02B | $3.12B | $2.90B | $2.88B | $2.79B | $2.78B | $3.10B | $3.08B | $3.15B | $3.26B | $3.29B | $3.76B | $2.81B | $2.41B | $2.58B | $2.39B | $2.13B | $2.15B |
| QoQ Change | — | +0.3% | +3.4% | -7.0% | -0.8% | -3.0% | -0.5% | +11.7% | -0.7% | +2.1% | +3.6% | +0.9% | +14.2% | -25.3% | -14.2% | +7.1% | -7.4% | -10.6% | +0.5% |
| YoY Change | — | — | — | — | -4.3% | -7.4% | -10.9% | +7.0% | +7.1% | +12.6% | +17.3% | +6.0% | +21.9% | -10.8% | -26.1% | -21.6% | -36.5% | -23.9% | -10.9% |
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) at Other Companies
Frequently Asked Questions
- What is CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
- CVS Health (CVS) reported short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) of $2.15B in Q4 2025.
- How has CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) changed year-over-year?
- CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) decreased by 10.9% year-over-year, from $2.41B to $2.15B.
- What is the long-term trend for CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
- Over 5 years (2020 to 2025), CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) has grown at a -6.5% compound annual growth rate (CAGR), from $3.00B to $2.15B.
- What does short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) mean?
- Long-term or restricted financial investments held by the company.